IHC analysis of 132 TET tumors and 16 normal thymic tissues revealed an association between a higher expression of XPO1 and more aggressive histologic subtypes (e.g., B2/B3 thymoma and thymic carcinoma) and advanced stages of disease. Here, XPO1 is linked to thymic carcinoma.